Nantahala Capital Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Buy |
|
|||||
|
2025
Q1 | $7.21M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $198K | Sell |
|
|||||
|
2023
Q1 | $1.42M | Buy |
|
|||||
|
2022
Q4 | $2.73M | Sell |
|
|||||
|
2022
Q3 | $1.82M | Sell |
|
|||||
|
2022
Q2 | $3.35M | Sell |
|
|||||
|
2022
Q1 | $4.8M | Sell |
|
|||||
|
2021
Q4 | $12.1M | Buy |
|
|||||
|
2021
Q3 | $15.2M | Buy |
|
|||||
|
2021
Q2 | $20.7M | Sell |
|
|||||
|
2021
Q1 | $23.1M | Buy |
|
|||||
|
2020
Q4 | $16.5M | Buy |
|
|||||
|
2020
Q3 | $13.2M | Buy |
|
|||||
|
2020
Q2 | $14.8M | Buy |
|